Published

Effects of psilocybin versus escitalopram on rumination and thought suppression in depression.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: BJPsych open
Date: 2022-09-06
Source: PubMed
DOI: 10.1192/bjo.2022.565
PubMed: 36065128

Authors

Barba T Buehler S Kettner H Radu C Cunha BG Nutt DJ Erritzoe D Roseman L Carhart-Harris R

Watch author

Derived topics and classifications

psilocybin Depression Mechanism of Action Receptor Pharmacology Clinical Trial Randomized Controlled Trial Drug Interactions Randomized Controlled Trial

Citation graph

0 referenced DOIs found in stored source metadata. 2 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

The efficacy and safety of psilocybin-assisted therapy for major depressive disorder: a meta-analytic review of clinical outcomes2026-04-21 Effects of psilocybin versus escitalopram on rumination and thought suppression in depression.2022-09-06

Related papers

Could psilocin rescue chronic, stress-accelerated, transcriptional aging in brain?UKnowledge (University of Kentucky) · 2025-03-04 Psychedelics and Psychotherapy: Is the Whole Greater than the Sum of its Parts?Clinical Pharmacology & Therapeutics · 2023-10-05 Psychedelics and mental health: reimagining care through science, insight, and compassion.Frontiers in pharmacology · 2025-01-01 Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelicsFrontiers in Psychiatry · 2024-11-06